Gene · 64321
NIH grants2,818
NIH grants whose papers are about the gene, through NIH's grant-paper links.
101 to 120 of 2,818
Download this page as JSON| Grant | Title | SOX17 papers | Newest fiscal year |
|---|---|---|---|
| R01DK072381 | Kidney Injury Molecule-1 in Epithelial Repair | 2 | 2025 |
| R01DK082590 | Regulation of pancreatic islet cell fate | 2 | 2025 |
| R01DK090570 | Defining the role of MafA in islet beta cells | 2 | 2025 |
| R01DK117861 | Molecular Mechanisms of Cholestatic Fibrogenesis | 2 | 2025 |
| R01DK118155 | Intersection of signaling pathways and transcription factors regulating islet development | 2 | 2025 |
| R01DK121557 | REGULATION OF HUMAN HEMATOPOIETIC STEM CELL FATE VIA MLLT3 ISOFORMS | 2 | 2025 |
| R01DK132387 | Local immune modulation for beta cell replacement therapy in type 1 diabetes | 2 | 2025 |
| R01EY022645 | Gene regulation of retinal cell differentiation | 2 | 2025 |
| R01GM083337 | cis-Acting Elements Regulating Developmental Control of Replication Timing | 2 | 2025 |
| R01HD094868 | Decoding cell states and tissue morphogenesis in the early mammalian embryo | 2 | 2025 |
| R01HD106285 | Pathological reprogramming of the m6A epitranscriptome in uterine fibroids | 2 | 2025 |
| R01HL045638 | Programming of PMN host-defense function during transendothelial migration | 2 | 2025 |
| R01HL057181 | Cardiogenesis: Molecular Mechanisms | 2 | 2025 |
| R01HL113006 | Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling | 2 | 2025 |
| R01HL134776 | The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension | 2 | 2025 |
| R01HL141387 | Novel Involvement of eNAMPT/TLR4 Signaling in PAH Vascular Remodeling and Right Ventricular Dysfunction | 2 | 2025 |
| R01HL146690 | Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy | 2 | 2025 |
| R01HL162794 | Fatty acid-binding proteins sustain endothelial glycolysis and arterial programming in pulmonary arterial hypertension | 2 | 2025 |
| R01HL164791 | The emerging role of apelin, RAAS, and ACE2 crosstalk in pulmonary hypertension | 2 | 2025 |
| R01HL164933 | Macrophage functional dynamics in adult heart regeneration | 2 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/grants?page=6